Viewing Study NCT03236857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-02-24 @ 3:14 PM
Study NCT ID: NCT03236857
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2017-07-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignancies View
None Acute Lymphoblastic Leukemia (ALL) View
None Acute Myeloid Leukemia (AML) View
None Non-Hodgkin's Lymphoma View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Venetoclax View
None pediatric View
None relapsed or refractory View
None Venclexta View